Penile prosthesis implantation for end-stage erectile dysfunction after radical prostatectomy

Area of Science:

• Urology
• Andrology
• Reconstructive Surgery

Background:

• Erectile dysfunction (ED) is a common complication following radical prostatectomy.
• Phosphodiesterase-5 inhibitor (PDE5i) therapy is a first-line treatment for post-prostatectomy ED.
• Many patients do not achieve satisfactory results with PDE5i therapy.

Purpose of the Study:

• To outline the treatment algorithm for erectile dysfunction after radical prostatectomy.
• To discuss second-line and third-line therapeutic options for refractory erectile dysfunction.
• To highlight the efficacy and safety of penile prosthesis implantation.

Main Methods:

• Review of current medical literature and treatment guidelines for post-prostatectomy erectile dysfunction.
• Discussion of established second-line therapies including vacuum constriction devices, intraurethral prostaglandins, and penile injection therapy.
• Evaluation of penile prosthesis implantation as a definitive treatment option.

Main Results:

• Second-line therapies provide alternatives when PDE5 inhibitors fail.
• Penile prosthesis implantation is the treatment of choice for men unresponsive or intolerant to second-line options.
• Modern 3-piece inflatable penile prostheses demonstrate high mechanical reliability (92-94%) and patient satisfaction.
• Antibiotic and hydrophilic coatings significantly reduce infection rates associated with penile implants.

Conclusions:

• A stepwise approach is recommended for managing erectile dysfunction post-radical prostatectomy.
• Penile prosthesis implantation offers a high success rate and natural-feeling results for refractory ED.
• Advancements in penile implant technology have improved device durability and reduced complication rates.